✦ LIBER ✦

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

✍ Scribed by Valerie J. Lewington; Alexander J. McEwan; Duncan M. Ackery; Russell J. Bayly; David H. Keeling; Patricia M. Macleod; Arthur T. Porter; Maureen A. Zivanovic

Book ID: 118275908
Publisher: Elsevier Science
Year: 1991
Weight: 720 KB
Volume: 27
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(91)90257-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7011 A double-blind, randomised dose-res

7011 A double-blind, randomised dose-response phase II, multicentre study of radium-223 for the palliation of painful bone metastases in castration refractory prostate cancer patients

✍ Nilsson, S.; Strang, P.; Franzén, L.; Olivier, P.; Pecking, A.; Staffurth, J.; V 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Double-blinded, Placebo-controlled Rando

Double-blinded, Placebo-controlled Randomized Study Evaluating the Efficacy of Risedronate to Prevent the Loss of Bone Mineral Density in Non-metastatic Prostate Cancer Patients Undergoing Radiotherapy Plus 2-3 Years of Androgen Ablation Therapy

✍ C. Choo; H. Lukka; A. Kiss; C. Danjoux 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Safety and Efficacy of the Specific Endo

Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial

✍ Nicholas D. James; Armelle Caty; Michael Borre; Bernard A. Zonnenberg; Philippe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 1000 KB

Results of a phase III study evaluating

Results of a phase III study evaluating the use of strontium89 therapy as an adjubant to local external beam radiotherapyy in patients with endocrine resistant metastatic prostate cancer — first results of the trans-Canada study

✍ A.T. Porter; A. McEwan 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Final safety and efficacy analysis of th

Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial

✍ Nicholas D. James; Armelle Caty; Heather Payne; Michael Borre; Bernard A. Zonnen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

3LBA SOLTI-0701: A double-blind, randomi

3LBA SOLTI-0701: A double-blind, randomized phase 2b study evaluating the efficacy and safety of sorafenib (SOR) compared to placebo (PL) when administered in combination with capecitabine (CAP) in patients (pts) with locally advanced (adv) or metastatic (met) breast cancer (BC)

✍ J. Baselga; J.G.M. Segalla; H. Roché; A. del Giglio; E.M. Ciruelos; S. Cabral Fi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB